Researcher.Life Logo

Endocrine-Related Cancer : Impact Factor & More

eISSN: 1479-6821pISSN: 1351-0088

Key Metrics

CiteScore
9.9
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q1Oncology
SNIP
1.52
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Endocrine-Related Cancer

Endocrine-Related Cancer Journal Specifications

Overview
Publisher BIOSCIENTIFICA LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1994
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Endocrine-Related Cancer ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Endocrine-Related Cancer

Body composition in recurrent prostate cancer and the role of steroidogenic genotype.
  • 26 Sep 2026
  • Endocrine-related cancer
DLK1 - a novel therapeutic target in cancer.
  • 22 Apr 2026
  • Endocrine-related cancer
Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+ stem cells.
  • 22 Apr 2026
  • Endocrine-related cancer
NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A Pilot Study.
  • 21 Apr 2026
  • Endocrine-related cancer
HMGCS1 as a Potential Mediator of Resistance to EZH2 Inhibition via Ferroptosis mediated by PI3K/AKT/mTOR Pathway in the Pancreatic Neuroendocrine Neoplasms.
  • 21 Apr 2026
  • Endocrine-related cancer
Mobile Elements in Pituitary Neuroendocrine Tumors: Integrative Evidence and Future Directions.
  • 21 Apr 2026
  • Endocrine-related cancer
Body composition in recurrent prostate cancer and the role of steroidogenic genotype.
  • 26 Sep 2026
  • Endocrine-related cancer
DLK1 - a novel therapeutic target in cancer.
  • 22 Apr 2026
  • Endocrine-related cancer
Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+ stem cells.
  • 22 Apr 2026
  • Endocrine-related cancer
NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A Pilot Study.
  • 21 Apr 2026
  • Endocrine-related cancer
HMGCS1 as a Potential Mediator of Resistance to EZH2 Inhibition via Ferroptosis mediated by PI3K/AKT/mTOR Pathway in the Pancreatic Neuroendocrine Neoplasms.
  • 21 Apr 2026
  • Endocrine-related cancer
Mobile Elements in Pituitary Neuroendocrine Tumors: Integrative Evidence and Future Directions.
  • 21 Apr 2026
  • Endocrine-related cancer

FAQs on Endocrine-Related Cancer